Injectafer® (ferric carboxymaltose injection) HCP

Please see full Important Safety Information below in the pinned post and at https://injectaferhcp.com/#isi-fixedbottom Select Important Safety Information Injectafer® (ferric carboxymaltose injection) is indicated for the treatment of iron deficiency anemia (IDA) in adult and pediatric patients 1 year of age and older who have either intolerance or an unsatisfactory response to oral iron, and in adult patients who have non-dialysis dependent chronic kidney disease. Injectafer is also indicated for iron deficiency in adult patients with heart failure and New York Heart Association class II/III to improve exercise capacity. Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Injectafer. The most common side effects of Injectafer include: • In adult patients: nausea, hypertension, flushing, injection site reactions, erythema, hypophosphatemia, and dizziness • In pediatric patients: hypophosphatemia, injection site reactions, rash, headache, and vomiting These are not all of the possible side effects of Injectafer. The risk information provided here is not comprehensive. Please see Full Prescribing Information for Injectafer, including the bolded WARNING regarding hypersensitivity at InjectaferHCP.com.